Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 8,339 | 0.1% | 10,803 | 12/31/2025 |
| 2025 Q3 | 10/31/2025 | 6,198 | 0.1% | 11,024 | 9/30/2025 |
| 2025 Q2 | 7/29/2025 | 6,243 | 0.1% | 11,892 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 7,749 | 0.1% | 12,218 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 9,316 | 0.1% | 13,078 | 12/31/2024 |
| 2024 Q3 | 11/6/2024 | 14,229 | 0.1% | 13,535 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 14,656 | 0.2% | 13,944 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 13,415 | 0.1% | 13,938 | 3/31/2024 |
| 2023 Q4 | 1/26/2024 | 12,577 | 0.1% | 14,320 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 12,282 | 0.2% | 14,924 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 11,140 | 0.1% | 15,503 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 12,627 | 0.2% | 15,368 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 11,027 | 0.1% | 15,283 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 10,216 | 0.1% | 14,830 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 8,698 | 0.1% | 14,714 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 9,938 | 0.1% | 14,229 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 9,773 | 0.1% | 15,476 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 9,320 | 0.1% | 15,401 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 8,528 | 0.1% | 15,269 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 6,884 | 0.1% | 14,550 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 6,390 | 0.1% | 13,227 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 7,654 | 0.1% | 13,673 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 8,447 | 0.1% | 13,544 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 5,313 | 0.1% | 10,881 | 3/31/2020 |
| 2019 Q4 | 2/11/2020 | 4,030 | 0.1% | 10,733 | 12/31/2019 |
| 2014 Q2 | 8/7/2014 | 2,374 | 0.1% | 8,404 | 6/30/2014 |
| 2014 Q1 | 5/9/2014 | 2,662 | 0.1% | 8,866 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 2,257 | 0.1% | 8,199 | 12/31/2013 |